Bullous morphea is an uncommon form of localized scleroderma. The pathogenesis is unknown and treatment of coexistent ulcers is difficult. The pathogenesis of bullae formation in morphea is multifactorial, but reactive oxygen species production appears to play a key role. We report a patient with bullous morphea with long-standing ulcers whom we successfully treated with N-acetylcysteine and topical wound care. N-acetylcysteine, an antioxidant sulfhydryl substance, promotes the healing of ulcers in patients with bullous morphea.
RosatoEBorgheseFPisarriSSalsanoF. The treatment with N-acetylcysteine of Raynaud's phenomenon and ischemic ulcers therapy in sclerodermic patients: A prospective observational study of 50 patients. Clin Rheumatol2009; 28:1379–84.
6.
TuffanelliDL. Lymphangiectasis due to scleroderma. Arch Dermatol1975; 111:1216.
7.
PetersMSSuWP. Eosinophils in lupus panniculitis and morphea profunda. J Cutan Pathol1991; 18:189–92.
8.
PautrierLM. Sclerodermie a evolution rapide, en plaques multiples. ýmportance des lesions vascularies initiales et tardives dans l'etude de la sclerodermie. Bull Soc Fr Dermatol1929; 36:928–38.
KerscherMVolkenandtMGrussCReutherTvon KobyletzkiGFreitagM. Low dose UVA1 phototherapy for treatment of localized scleroderma. J Am Acad Dermatol1998; 38:21.
11.
El-MoftyMZaherHBosseilaMYousefRSaadB. Low-dose broad-band UVA in morphea using a new method for evaluation. Photodermatol Photoimmunol Photomed2000; 16:43.
12.
NagaiMHasegawaMTakeharaKSatoS. Novel autoantibody to Cu/Zn superoxide dismutase in patients with localized scleroderma. J Invest Dermatol2004; 122:594–601.
13.
MartinLKKirsnerRS. Ulcers caused by bullous morphea treated with tissue-engineered skin. Int J Dermatol2003; 42:402–4.
